MYND Life Sciences Inc.
MYND
CNSX
07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 400.00 | 1.30K | 200.00 | 200.00 | 100.00 |
Total Receivables | 438.60K | 501.80K | 570.10K | 560.10K | 5.10K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | 9.30K | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 6.00K | 8.20K | 1.90K | -- | 7.00K |
Total Current Assets | 445.00K | 511.30K | 572.20K | 569.60K | 12.20K |
|
|||||
Total Current Assets | 445.00K | 511.30K | 572.20K | 569.60K | 12.20K |
Net Property, Plant & Equipment | 3.70K | 3.80K | 4.40K | 4.70K | 19.40K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 72.40K | -- | -- | -- | 228.10K |
Total Assets | 521.00K | 515.10K | 576.50K | 574.20K | 259.70K |
|
|||||
Total Accounts Payable | 897.00K | 841.50K | 934.60K | 788.40K | 1.01M |
Total Accrued Expenses | 319.20K | 388.80K | 371.50K | 322.50K | 283.90K |
Short-term Debt | 2.17M | 2.18M | 2.24M | 2.16M | 2.26M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.47M | 1.18M | 1.03M | 886.90K | 867.00K |
Total Other Current Liabilities | 1.47M | 1.18M | 1.03M | 886.90K | 867.00K |
Total Current Liabilities | 4.86M | 4.60M | 4.58M | 4.16M | 4.42M |
|
|||||
Total Current Liabilities | 4.86M | 4.60M | 4.58M | 4.16M | 4.42M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 2.17M | 2.18M | 2.24M | 2.16M | 2.26M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 0.00 | -- | -- |
Total Liabilities | 4.86M | 4.60M | 4.58M | 4.16M | 4.42M |
|
|||||
Common Stock & APIC | 3.19M | 3.20M | 3.29M | 3.17M | 3.33M |
Retained Earnings | -7.62M | -7.38M | -7.39M | -6.85M | -7.59M |
Treasury Stock & Other | 95.50K | 96.00K | 98.60K | 95.00K | 100.30K |
Total Common Equity | -4.34M | -4.08M | -4.00M | -3.58M | -4.16M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -4.34M | -4.08M | -4.00M | -3.58M | -4.16M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.34M | -4.08M | -4.00M | -3.58M | -4.16M |
|